![Major Bacitracin 500 [USP'U]/g Ointment, 144 packets — NDC 00904-7402-67 package photo](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=13288efb-e282-68f8-e063-6294a90ae712&name=701378+Major+Bacitracin+Ointment+0.9g+144ct+120723+CDER.jpg)
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Major Bacitracin 500 [USP'U]/g Ointment, 144 packets — NDC 0904-7402-67 (Billing 00904-7402-67)
by Major Pharmaceuticals · 144 PACKET in 1 CARTON / .9 g in 1 PACKET
This is a package of 144 packets of Major Bacitracin 500 [USP'U]/g Ointment from Major Pharmaceuticals, marketed since Mar 2024 and currently FDA-listed; retail pharmacies pay about $0.1207 per packet (NADAC). It is this product's only package size.
NDC 00904-7402-67
🏷️ FDA NDC (as labeled)
0904-7402-67
billing pads the labeler segment with a zero
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 0904-7402-67 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 0904 labeler · 7402 product · 67 package
- Package marketed since
- Mar 8, 2024
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Billing quantity
- 144 EA per package
- Barcode (UPC)
- 0309047402670
- Medicaid fills, this package
- 519 prescriptions in the last four reported quarters
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
0904-7402-67
Product NDC
0904-7402
11-digit billing NDC
00904740267
NCPDP billing unit
EA — each (per item)
RxCUI
1648110
UNII
58H6RWO52I
UPC
0309047402670
Application #
M004
SPL Set ID
13288efb-e282-68f8-e063-6294a90ae712
Physiologic effect
Decreased Cell Wall Synthesis & Repair
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2024-03-08
Route
TOPICAL
Dosage form
OINTMENT
Substance
BACITRACIN
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
90100010004210
GCN Seq No
030027
GCN
31811
HICL code
004047
Ingredient (HICL)
Bacitracin
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q5
Therapeutic class — intermediate (HIC2)
Agents Acting Principally On The Skin
HIC3 code
Q5W
Therapeutic class — specific (HIC3)
Topical Antibiotics
AHFS code
84:04.04.00
AHFS class
Antibacterials (84:04)
FDB label name
BACITRACIN 500 UNIT/GM OINTMNT
FDB brand name
Bacitracin
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 030027
- GCN: 31811
- GPI-14 (Medi-Span): 90100010004210
- HICL (First Databank): 004047
- AHFS class code: 84:04.04.00
- RxCUI (RxNorm): 1648110
Why two NDCs?
The FDA registers this code as 0904-7402-67 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-7402-67. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
RxNorm drug class
This medicine belongs to the Other antibiotics for topical use class.
Drug family (ATC)
Other antibiotics for topical use, Other antibacterials, Antibiotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Label name BACITRACIN 500 UNIT/GM OINTMNT Ingredient Bacitracin
📗 Our plain-language guide HelloPharmacist
- It is first aid to help prevent infection in minor cuts, scrapes, and burns. One cream product also has directions for athlete's foot, ringworm and jock itch.
- Clean the area, then put on a small amount, about the size of your fingertip. Do this 1 to 3 times a day, and you can cover it with a sterile bandage. One cream product is used as...
- Not longer than 1 week unless a doctor tells you to. If the problem is not getting better or gets worse, stop and check with a doctor.
- Stop if you get a rash or any allergic reaction, and talk to a doctor. Don't use it if you are allergic to any ingredient.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Bacitracin — tap one for details:
7
Nutrient depletion considerations
Bacitracin may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.
BIOTIN
Insignificant Depletion
FOLIC ACID
Insignificant Depletion
RIBOFLAVIN
Insignificant Depletion
THIAMINE
Insignificant Depletion
VITAMIN B12
Insignificant Depletion
+2 more
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
💬 Questions about Bacitracin?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.121 | $17.38 / 144 packets |
| Medicaid paysCMS SDUD · 12 mo | $0.7363 | $106.03 / 144 packets |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file · file of Jan 14, 2026
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · through Q1 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00904-7402-67 You're viewing this Main listing | 144 PACKET in 1 CARTON / .9 g in 1 PACKET | 2024-03-08 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Bacitracin 500 U/g 00536-1256-28 | RUGBY | 30 g | $0.055 | — | Availability likely | save 54% |
| Bacitracin 500 [USP'U]/g 00713-0280-31 | Cosette | 28.4 g | $0.073 | — | Availability likely | save 39% |
| Bacitracin 500 [iU]/g 68001-0477-46 | BluePoint | 1 tube | $0.094 | — | Availability likely | save 22% |
| Bacitracin 500 [USP'U]/g 45802-0060-01 | Padagis | 1 tube | $0.117 | — | Availability likely | save 3% |
| Major Bacitracin 500 [USP'U]/gthis 00904-7402-67 | Major | 144 packets | $0.121 | — | FDA listed | — |
| signature care first aid antibiotic 500 [USP'U]/g 21130-0757-64 | Safeway | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 30142-0536-64 | Kroger | 1 tube | — | — | FDA listed | — |
| Antibiotic 500 [USP'U]/g 36800-0536-64 | Topco | 1 tube | — | — | FDA listed | — |
| bacitracin 500 [USP'U]/g 37808-0536-64 | H | 1 tube | — | — | FDA listed | — |
| MediChoice Bacitracin 500 [iU]/g 39892-0810-01 | O&M | 144 packets | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 41226-0880-02 | Kroger | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 41250-0844-64 | Meijer | 1 tube | — | — | FDA listed | — |
| first aid antibiotic 500 [USP'U]/g 42507-0536-64 | HyVee | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 50090-0815-00 | A-S | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 50090-0845-00 | A-S | 144 packets | — | — | FDA listed | — |
| Rexall Antibiotic 500 [USP'U]/g 55910-0536-64 | Dolgencorp, | 1 tube | — | — | FDA listed | — |
| Publix Bacitracin Zinc 500 [USP'U]/g 56062-0815-28 | PUBLIX | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 59779-0536-64 | CVS | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [iU]/g 63187-0299-01 | Proficient | 28.35 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/1000mg 67777-0116-10 | Dynarex | 144 packets | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 68071-5253-03 | NuCare | 28.4 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 68788-8643-02 | Preferred | 28.4 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 68788-9794-02 | Preferred | 28 g | — | — | FDA listed | — |
| TheraCare Bacitracin Zinc 500 [USP'U]/g 71101-0019-01 | Veridian | 1 tube | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 71205-0057-01 | Proficient | 28.4 g | — | — | FDA listed | — |
| Vitastem Ultra First Aid Antibiotic 500 U/g 71262-0013-15 | Viaderma | 1 bottle | — | — | FDA listed | — |
| Viaderma Care First Aid 500 U/g 71262-0015-15 | ViaDerma | 1 bottle | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 71335-2731-01 | Bryant | 144 packets | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 72162-2280-02 | Bryant | 144 packets | — | — | FDA listed | — |
| astonea First Aid 500 [USP'U]/g 77338-0303-52 | ASTONEA | 9 g | — | — | FDA listed | — |
| Bacitracin 500 [USP'U]/g 84387-0002-01 | ALLIED | 28.4 g | — | — | FDA listed | — |
| Bacitracin 500 [iU]/g 87236-0000-01 | AlderMed | 1 tube | — | — | FDA listed | — |
| Medi-First Bacitracin Zinc 500 [USP'U]/g 47682-0863-66 | Unifirst | 1 tube | — | — | FDA listed | — |
| Zapotol Bacitracin 500 [USP'U]/g 59428-0135-14 | Zapatol | 1 tube | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file · file of Jan 14, 2026
Availability & generic status
🏛️
2024
On the market since
Mar 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Bacitracin Topical inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII T5L8T28FGP
Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
-
UNII 4T6H12BN9U
Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
2 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesmineral oil, petrolatum
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 8, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerMajor Pharmaceuticals
FDA applicationM004 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedMar 2024
Product typeHuman Otc Drug
Portfolio630 products on file
More NDCs from Major Pharmaceuticals labeler code 00904
- Febuxostat 80 mg Tablet, Film Coated NDC 0904-7396-46
- Pirfenidone 267 mg Tablet, Film Coated NDC 0904-7397-53
- Pirfenidone 801 mg Tablet, Film Coated NDC 0904-7398-89
- Roflumilast 500 ug Tablet NDC 0904-7399-46
- Cyclobenzaprine Hydrochloride 5 mg Tablet, Film Coated NDC 0904-7400-04
- Cyclobenzaprine Hydrochloride 10 mg Tablet, Film Coated NDC 0904-7401-61
- Clozapine 50 mg Tablet NDC 0904-7406-61
- Moxifloxacin Hydrochloride 400 mg Tablet, Film Coated NDC 0904-7407-04
- Pseudoephedrine hydrochloride 120 mg Tablet, Film Coated NDC 0904-7409-15
- Amitriptyline Hydrochloride 25 mg Tablet NDC 0904-7410-61
- Amitriptyline Hydrochloride 50 mg Tablet NDC 0904-7411-61
- varenicline .5 mg Tablet, Film Coated NDC 0904-7413-35
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 Ask a Doctor Before Use If
📄 Stop Use and Ask a Doctor If
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses First Aid to help prevent infection in minor cuts scrapes burns
⏱️ Dosage and Administration ▾
Directions Clean the affected area and dry thoroughly Apply a small amount of the product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily May be covered with a sterile bandage
⚠️ Warnings ▾
Warnings For External Use Only.
📦 Storage and Handling ▾
Storage Information Store at 15° to 25°C (59° to 77°F).
🧪 Active Ingredient ▾
Active Ingredient Bacitracin 500 Units per gram
🧪 Inactive Ingredients ▾
Inactive Ingredients mineral oil, petrolatum
🎯 Purpose ▾
Purpose First Aid Antibiotic
📄 Do Not Use ▾
Do Not Use in eyes over large areas of the body if you are allergic to any of the ingredients
📄 Ask a Doctor Before Use If ▾
Ask Doctor before Use if you have deep or puncture wounds, animal bites or serious burns.
📄 Stop Use and Ask a Doctor If ▾
Stop Use and Ask Doctor if The condition persists or gets worse A rash or allergic reaction develops
📄 Keep Out of Reach of Children ▾
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.
📄 Questions or Comments ▾
Questions Call 1-888-296-9067
📄 Package Label / Principal Display Panel ▾
Packaging 701378 Major Bacitracin Ointment 0.9g 144ct 120723 CDER
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
519
Units reimbursed last 4 qtrs
23.8K
Gross reimbursed last 4 qtrs
$17.5K
Avg / prescription
$33.74
Avg / unit
$0.7363
Latest quarter Q1 2026
84Rx
Medicaid pays / ea
$0.7363
gross reimbursed
vs
NADAC / ea
$0.1207
acquisition cost
=
Spread
+$0.6156
+510% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 159 Rx Managed care · 360 Rx
State Medicaid map
Units reimbursed · per 100k residents
5.143.9
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Bacitracin (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Bacitracin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.9K
Claims incl. refills
44
Beneficiaries
42
Spend / beneficiary
$92.36
Spend / claim
$88.16
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.